AI assistant
Sending…
RESMED INC — Director's Dealing 2012
Mar 9, 2012
30071_dirs_2012-03-09_aec84f92-ee9e-4d54-b99a-6d4308e71065.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-03-07
Reporting Person: FARRELL PETER C (Director, Executive Chairman and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-03-07 | ResMed Common Stock | G | 200000 | — | Disposed | 326959 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 3317 | Indirect |
| ResMed Common Stock | 21391 | Indirect |
| ResMed Common Stock | 200000 | Indirect |
| ResMed Common Stock | 200000 | Indirect |
| ResMed Common Stock | 200000 | Indirect |
| ResMed Common Stock | 200000 | Indirect |
Footnotes
F1: Transaction represents a gift from the Peter C. Farrell Trust to fund the Peter C. Farrell February 2012 Annuity Trust. Dr. Farrell is the trustee of his personal trust, but is not the trustee of the Annuity Trust. Per the terms of the Annuity Trust, 90% of the original value will be transferred to Dr. Farrell at the end of the Trust's first year.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29